Immunome, Inc. (IMNM)
19.37
+0.66
(+3.53%)
USD |
NASDAQ |
Nov 09, 16:00
19.37
0.00 (0.00%)
After-Hours: 18:20
Immunome Gross Profit (Annual) : 3.986M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.986M |
| December 31, 2024 | 6.939M |
| December 31, 2023 | 13.29M |
| December 31, 2022 | -0.631M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.755M |
| December 31, 2020 | -0.755M |
| December 31, 2019 | -0.615M |
| December 31, 2018 | -0.521M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 805.52M |
| Revolution Medicines, Inc. | -16.56M |
| Erasca, Inc. | -3.107M |
| Oncolytics Biotech, Inc. | -0.07M |
| Sangamo Therapeutics, Inc. | 31.95M |